Your shopping cart is currently empty

SRX246 has no interaction at V1b and V2 receptors. SRX246 shows negligible binding at 64 other receptors classes, including 35 G-proteincoupled receptors. SRX246 is a potent and CNS-penetrant vasopressin 1a (V1a) receptor antagonist (Ki=0.3 nM for human V1a).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $987 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $1,360 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $1,860 | 8-10 weeks | 8-10 weeks |
| Description | SRX246 has no interaction at V1b and V2 receptors. SRX246 shows negligible binding at 64 other receptors classes, including 35 G-proteincoupled receptors. SRX246 is a potent and CNS-penetrant vasopressin 1a (V1a) receptor antagonist (Ki=0.3 nM for human V1a). |
| Targets&IC50 | V1a receptor (human):(ki)0.3 nM |
| In vivo | SRX246 (2 mg/kg; i.v.) treatment results in plasma pharmacokinetic values of Cmax 953 ng/mL, AUC0-∞ 1141 ng∙h/mL, and t1/2 6.02 hours. SRX246 (20 mg/kg; p.o.) administration yields Cmax 98.4 ng/mL, AUC0-∞ 624 ng∙h/mL, and t1/2 2.38 hours, respectively [1]. |
| Molecular Weight | 703.87 |
| Formula | C42H49N5O5 |
| Cas No. | 512784-93-9 |
| Smiles | C[C@@H](NC(=O)[C@@H](CC(=O)N1CCC(CC1)N1CCCCC1)N1[C@H](\C=C\c2ccccc2)[C@H](N2[C@H](COC2=O)c2ccccc2)C1=O)c1ccccc1 |
| Relative Density. | 1.281 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.